BioInsights - Report

Cell & Gene Therapy INSIGHTS

Business Insights January 2021

February 2021

Download full report

Business Insight: cell & gene therapy

J Mulryne,

D San Martin,

J Schmidt et al.

1 February 2021

Expert Insight

Read more

Previous reports

Business Insights February 2022

Business Insights February 2022

FEATURING

COMMENTARY: Regenerative medicine: new paradigms

J Lambert

COMMENTARY: Advancing patient access to cell & gene therapies: partnerships, pilots, & psyche

H McDonald

INTERVIEW: Building from the ground up: business culture learnings for cell and gene therapy biotechs

J Noble

Read more

Business Insights October 2021

Business Insights October 2021

FEATURING

INTERVIEW: Establishing gene therapies as a relevant, recognized and accessible therapeutic category

T Salimullah

INTERVIEW: Analyzing trends and opportunities in the advanced therapy tool and service provider sectors

D Anderson

Read more

Business Insights July 2021

Business Insights July 2021

FEATURING

EXPERT INSIGHT: Solving the problem of financing one-time treatments with evidence uncertainty: which types of outcomes-based payment models could work best for novel CAR-T therapies in multiple myeloma? A systematic review of the published literature

C Dietrich,

C Hague,

S Boes

COMMENTARY: Critical need for establishing value that justifies the current rising costs of cell and gene therapy

R Maziarz

Read more

Other reports from Cell and Gene Therapy insights

Read more

Read more

Read more

Read more